Showing 1 - 3 of 3
Persistent link: https://www.econbiz.de/10005508933
National guidelines recommend angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin receptor blockers (ARBs) therapy for diabetic patients with hypertension and/or proteinuria to hinder renal disease progression. However, little is known about the adequacy of adherence to these...
Persistent link: https://www.econbiz.de/10010573169
Objectives National guidelines recommend angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin receptor blockers (ARBs) therapy for diabetic patients with hypertension and/or proteinuria to hinder renal disease progression. However, little is known about the adequacy of adherence to...
Persistent link: https://www.econbiz.de/10009023913